Can J Anaesth 70(8):12811286 Buhl T, Thim L, Kofod H, Orskov C, Harling H, Holst JJ (1988) Naturally occurring products of proglucagon 111160 in the porcine and human small intestine
avoiding plunger movement that could impact sterility or headspace conditions)
Short-acting GLP-1 Drug segment held a market size of USD 13.52 Billion in 2025, representing 36% of the total GLP-1 Drug Market share, and is expected to grow at a CAGR of 24.3% driven by increasing demand for rapid glucose management and targeted therapeutic applications
"Most chronic disease isn't driven by fat mass but low levels of muscle mass and inactivity." Priya Sumithran, a researcher at the University of Melbourne's Department of Medicine in Australia and head of obesity medicine at the healthcare provider Austin Health, echoed his points
Optimized LC-MS/MS parameters for the analysis of eicosanoids are in accordance with previous research (Meng et al., 2016)